Skip to main content

Table 1 Data sources, population type, summary statistics for overall QOL

From: Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales

Patient category

N

Mean

Median

Minimum

Maximum

Standard deviation

Advanced cancer

120

7.26

8.10

0.20

9.70

2.31

Brain cancer

26

6.46

7.00

2.00

9.00

1.88

Breast cancer

296

7.77

8.20

1.40

10.00

1.84

Lung cancer

1155

7.25

7.80

0.00

10.00

2.10

Colon cancer −2 Wks Post Surgery (Colectomy)

388

7.57

8.00

1.50

10.00

1.80

Colon cancer-Pre Surgery (Colectomy)

403

8.06

8.50

2.00

10.00

1.75

GI cancer

2409

7.74

8.30

0.00

10.00

1.86

GU cancer

180

8.29

9.00

2.40

10.00

1.61

Gynecologic cancer

117

7.83

8.20

1.80

10.00

1.75

Head and neck cancer

254

7.24

7.80

0.00

10.00

2.27

Hematologic cancer

32

7.33

7.70

1.70

9.30

2.03

Lymphatic cancer

8

7.21

8.45

3.20

9.20

2.51

Multiple site cancer

14

8.02

8.00

6.00

10.00

1.56

Musculoskeletal site cancer

18

6.68

7.55

1.80

10.00

2.78

Neurologic cancer

214

7.42

8.00

1.00

10.00

1.90

Other cancer

52

7.91

8.80

1.00

10.00

2.34

Lung cancer- Mayo study

529

7.03

7.00

0.00

10.00

2.18

Lung cancer - Mayo study 6 months post diagnosis

1409

7.05

7.60

0.00

10.00

2.40

Skin cancer

7

7.59

7.90

5.90

9.40

1.17

Unknown site cancer

29

6.60

7.00

2.10

10.00

2.25

Healthy NCCTG volunteers

54

8.31

9.00

5.00

10.00

1.19

Hospice caregivers

53

7.44

7.50

3.75

10.00

1.74

Hospice

52

5.89

5.75

2.00

9.75

2.03

Minnesota medical students

543

7.16

7.00

1.00

10.00

1.76

Mayo physicians

460

7.30

7.00

1.00

10.00

1.69

Mayo residents

295

6.46

7.00

1.00

10.00

1.91

  1. GI, gastroenterological; GU, genitourinary; NCCTG, North central chapter treatment group.
  2. Distributions for the various cohorts of Table 1 are displayed in Figures 2 and 3.